Lupin Share Price

ABOUT Lupin

• Industry Biotechnology & Drugs
• ISIN INE326A01037
• BSE Code 500257
• NSE Code LUPIN

Lupin Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti Inflammatory Drug therapy segments and is engaged in the Anti-TB and Cephalosporins segments. The Company along with its subsidiaries has manufacturing locations spread across India, United States of America, Mexico and Brazil with trading and other incidental and related activities extending to the global markets. Its complex generics portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol and others. Its biosimilar products include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim) and Etanercept. It diabetes brands include ONDERO and ONDERO MET.

MANAGEMENT

• Vinita Gupta Chief Executive Officer, Executive Director
• Ramesh Swaminathan Executive Director, Global Chief Financial Officer, Chief Risk Officer, Head - Corporate Affairs
• Rajendra Chunodkar President - Manufacturing Operations
• Fabrice Egros President - Corporate Development and Growth Markets
• Shahin Fesharaki President - Global Chief Scientific Officer
• Spiro Gavaris President - U.S. Generics
• Naresh Gupta President - API Plus and Global TB
• Rajender Kamboj President - Novel Drug Discovery and Development
• Cyrus Karkaria President - Biotechnology
• Yashwant Mahadik President - Global Human Resources